Multiple Sclerosis (MS)

About Multiple Sclerosis (MS)

Multiple Sclerosis (MS) is a chronic, immune-mediated neurodegenerative disorder of the central nervous system (CNS) characterized by abnormal immune attacks that damage the protective insulation surrounding nerve fibers, disrupting the transmission of electrical signals between the brain, spinal cord, and the rest of the body.

Because lesions can occur anywhere within the central nervous system, symptoms are highly variable and unpredictable, manifesting across four primary domains:

Sensory & Visual Disturbances: Numbness, tingling, chronic pain, or burning sensations; optic neuritis leading to blurry vision, double vision (diplopia), loss of color perception, or painful eye movement.

Motor & Coordination Deficits: Muscle weakness, spasticity (stiffness/spasms), impaired balance and gait (ataxia), tremors, and difficulty with fine motor tasks.

Fatigue & Autonomic Functions: Profound, disproportionate fatigue unalleviated by rest; bladder and bowel dysfunction; heat sensitivity (Uthoff's phenomenon), where minor body temperature increases temporarily worsen symptoms.

Cognitive & Neuropsychiatric Shifts: Lags in information processing speed, impaired short-term memory, executive dysfunction, depression, and mood lability.

Current leading research indicates that many neurodegenerative diseases may be heavily influenced by lifestyle and environmental factors including chronic inflammation, toxin exposure, nutritional and hormonal deficits, metabolic dysfunction, physical / emotional trauma, and vascular issues.

Frequency: Nearly 1 million people are currently living with MS in the United States. This translates to a frequency of roughly 3 to 4 cases per 1,000 adults (about 300 to 377 cases per 100,000 people), making it the most common progressive neurological disorder affecting young adults.

Age Distribution: The typical age of MS diagnosis is between 36 and 40 years old, though symptoms frequently begin a few years prior to clinical diagnosis.

Gender Differences: MS is diagnosed in females nearly 3 times more often than in males; roughly 74% of people with MS in the U.S. are women.

Race & Ethnicity: The highest prevalence rate is among non-Hispanic White individuals (374.8 per 100,000), followed closely by non-Hispanic Black individuals (298.4 per 100,000). The condition is less frequent in Hispanic and Asian populations.

Types and classifications

• Conventional neurologists classify MS based on the clinical timelines and symptom pacing (how often flare-ups happen). The types include:
• Relapsing-Remitting MS (RRMS): This is the most common form, affecting about 85% of people at initial diagnosis. It is characterized by clearly defined attacks of new or worsening neurological symptoms (relapses), followed by periods of partial or complete recovery (remissions) where the disease does not progress.
• Secondary Progressive MS (SPMS): This type follows an initial relapsing-remitting course. Over time, the disease transitions into a steady, progressive worsening of neurological function, with or without occasional relapses or minor plateaus.
• Primary Progressive MS (PPMS): This form affects about 15% of people with MS. It is characterized by a steady accumulation of disability and worsening symptoms from the very beginning, without any early relapses or remissions.
• Clinically Isolated Syndrome (CIS): This is a single, first episode of neurological symptoms caused by inflammation and demyelination in the central nervous system. While it lasts at least 24 hours, it does not yet meet the full criteria for an MS diagnosis, though it indicates a high risk of developing RRMS.
• Functional practitioners and functional neurologists do not define new or separate fundamental types of multiple sclerosis (MS). Instead, they use the standard clinical classifications established by standard neurology—Relapsing-Remitting MS (RRMS), Primary Progressive MS (PPMS), Secondary Progressive MS (SPMS), and Clinically Isolated Syndrome (CIS)—while focusing on underlying metabolic or neural network triggers rather than changing the disease categories themselves. They define the root cause for each type as follows:
• Relapsing-Remitting MS (RRMS): An acute, threshold-dependent immune tolerance failure. The patient’s underlying "toxic bucket" is full, and random triggers cause the immune system to periodically overflow and attack the myelin sheath. Primary drivers include intestinal permeability (i.e. "leaky gut"), latent viral load (i.e. flare-ups are often driven by the reactivation of dormant viruses), and acute stressors which can include mold and heavy metal exposure as well as psychological trauma.
• Secondary Progressive MS (SPMS): A shift from an active immune-driven disease to a cellular energy crisis (mitochondrial collapse). The problem is no longer just an active immune attack; it is that the engines of the nerve cells have burnt out from chronic inflammation, preventing tissue repair. Primary drivers here include mitochondrial decay where chronic oxidative stress damages the mitochondria within neurons, starving the nerves of energy; microglial activation, where microglia get permanently stuck in an aggressive, inflammatory state, eating away at healthy brain tissue; and nutrient depletion.
• Primary Progressive MS (PPMS): A profound, deep-seated neurodegenerative state coupled with an early loss of immune self-tolerance. Instead of a hyper-reactive immune system that flares up, the body experiences a slow, unremitting, systemic "smoldering fire." The primary drivers are seen as myelin regeneration failure often due to severe fatty acid malabsorption, advanced cellular membrane damage, or genetic variations affecting methylation; high total body burden frequently tied to historical, deeply embedded toxin accumulation; and advanced axis breakdown which is a total breakdown of the gut-immune-endocrine axis, leaving the body with limited natural anti-inflammatory reserves (like cortisol or regulatory T-cells) to suppress baseline neurodegeneration.

Symptoms associated in the NPA database

The NPA Treatment Database groups the following symptom information with Multiple Sclerosis (MS). This list is educational and is not a diagnostic checklist.

Treatment information in the database

The NPA Treatment Database lists 27 treatment records in connection with Multiple Sclerosis (MS). A database relationship does not establish that a treatment is effective, safe, or appropriate for any individual.

• Anat Baniel Method NeuroMovement
• Apollo Health / Dr. Dale Bredesen Protocol
• BrainHQ
• Dance & Movement Therapy
• Designs for Strong Minds
• Dr. Antonucci Functional Neurology (Concussion & Neurorehab)
• EksoNR (Ekso Bionics)
• Expiratory Muscle Strength Training (EMST)
• Feldenkrais Method®
• Functional & Neuromuscular Electrical Stimulation (FES/NMES)
• Hyperbaric Oxygen Therapy (HBOT)
• Interactive Metronome (IM)
• KAATSU / Blood Flow Restriction Training
• LearningRx
• Lee Silverman LSVT BIG
• Lokomat (Hocoma)
• Meditation / Mindfulness
• Mindset Reframing
• PoNS™ (Portable Neuromodulation Stimulator)
• Robotic and Exoskeleton Gait Training
• Specialized Neurorehabilitation Centers and Hospitals
• Tai Chi
• Task-Specific Training
• The Wahls Protocol
• Vagus Nerve Stimulation (VNS)
• Virtual Reality (VR) Therapy
• Yoga

Related questions

These controlled question pages use the same stored condition and treatment relationships.

• What treatments are listed for Multiple Sclerosis (MS) in the NPA database?

Recommended reading listed by NPA

These titles come from the current NPA condition record. Structured citation details are not yet available.

• Navigating Life with Multiple Sclerosis by Kathleen Costello, ANP-BC, MSCN et al. (American Academy of Neurology) — An authoritative AAN guide covering disease understanding, symptom management, wellness, and shared decision-making.
• Overcoming Multiple Sclerosis: The Evidence-Based 7-Step Recovery Program by George Jelinek, M.D. — An evidence-based lifestyle program shown to help many people with MS live well and reduce disease activity.
• Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life by Michael Merzenich, PhD — From a pioneering neuroscientist, practical principles for driving positive brain change at any age through targeted practice and experience.
• The Brain That Changes Itself: Stories of Personal Triumph from the Frontiers of Brain Science by Norman Doidge — Landmark exploration of neuroplasticity featuring dramatic recoveries from stroke, brain injury, and other neurological challenges.
• The Brain's Way of Healing: Remarkable Discoveries and Recoveries from the Frontiers of Neuroplasticity by Norman Doidge — Shows how light, sound, vibration, and movement can awaken the brain's self-healing capacities after injury and illness.
• The MSing Link: A Comprehensive Guide to Improving Mobility and Managing MS Symptoms by Gretchen Hawley — MS-specific exercise and neuroplasticity strategies focused on improving walking, balance, strength, and reducing fatigue.
• The Wahls Protocol: How I Beat Progressive MS Using Paleo Principles and Functional Medicine by Terry Wahls, M.D. with Eve Adamson — Dr. Wahls' personal and clinical protocol using intensive nutrition, lifestyle, and functional medicine to reverse progressive MS symptoms.